Skip to Primary Navigation

FTC resolves Express Scripts case with ‘landmark settlement’

A photo of seal on the US Federal Trade Commission on wall of headquarters in Washington, DC.
Photo: Kevin Carter/Getty Images

The pharmacy benefits manager has copped to artificially inflating the list price of drugs by using unfair rebating practices.

The Federal Trade Commission (FTC) has announced a “landmark settlement” with Cigna Group’s Express Scripts, Inc., and its affiliated entities (collectively “ESI”), one of the nation’s largest pharmacy benefit managers.

The settlement requires ESI to adopt “fundamental changes” to its business practices that increase transparency and bring millions of dollars